Sector valuations GC Genome Corporation
Stocks
A340450
KR7340450006
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,860.00 KRW | +0.21% |
|
-8.82% | -28.74% |
| 09/12 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 12/25/12 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 1.42x | - | 13.83x | - | 7.49Cr | ||
| -139.71x | 17.73x | -15.57x | 11.48x | -158.84x | -127.82x | -.--% | 3.31TCr | ||
| 17.77x | 2.23x | 0.47x | 1.74x | 10.03x | 12.09x | 1.14% | 2.1TCr | ||
| 16.09x | 1.14x | 0.96x | 1.28x | 7.26x | 13.26x | 5.41% | 694.55Cr | ||
| 275.59x | - | -1.55x | - | - | - | - | 422.58Cr | ||
| 53.92x | 11.11x | 13.81x | 9.52x | 33.43x | 42.32x | 0.86% | 289.84Cr | ||
| -19.69x | - | -0.06x | - | - | - | - | 175.19Cr | ||
| 33.69x | 1.64x | -0.11x | 1.47x | 11.96x | 20.41x | 1.6% | 168.3Cr | ||
| 28.61x | 1.7x | 0.04x | 1.15x | 9.52x | 13.45x | 0.88% | 164.68Cr | ||
| 11.74x | 1.57x | 0.87x | 1.25x | 4.87x | 8.34x | 6.44% | 157.93Cr | ||
| 81.93x | 14.72x | 4.18x | 17.06x | 42.12x | 57.43x | 0.12% | 148.77Cr | ||
| -24.97x | - | 0.53x | - | - | - | -.--% | 144.93Cr | ||
| 57.26x | 7.89x | 1.54x | 6.85x | 28.28x | 40.88x | 0.37% | 121.46Cr | ||
| 30.5x | 1.28x | -1.98x | 0.76x | 6.3x | 21.56x | 3.99% | 107.9Cr | ||
| -4.65x | 0.62x | -2.57x | 1.27x | -6.71x | -3.26x | - | 107.22Cr | ||
| 43.79x | 13.45x | 2.15x | - | - | - | 1.99% | 91Cr | ||
| 18.1x | 1.05x | 0.82x | - | - | - | 3.38% | 83Cr | ||
| 24.25x | 1.82x | 0.95x | - | - | - | 0.4% | 75Cr | ||
| -38.42x | - | 1.29x | 160.56x | -35.02x | -33.25x | - | 54Cr | ||
| 27.5x | 1.07x | 0.08x | 1.28x | 6.02x | 10.64x | 4.11% | 52Cr | ||
| Average | 25.96x | 5.27x | 0.31x | 15.51x | -3.14x | 6.42x | 2.05% | 423.82Cr | |
| Weighted average by Cap. | -29.37x | 9.53x | -5.39x | 7.78x | -63.95x | -47.49x | 1.17% |
- Stock Market
- Stocks
- A340450 Stock
- Sector GC Genome Corporation
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















